Houston Gene Therapeutics video presentation for investors.

Adeno-associated virus (AAV)-based gene therapy is a new type of medical treatment which is competing favorably with older medical treatment technologies. The medical treatment part comes from the use of human genes as “drugs” to treat disease, as opposed to small molecule drugs, otherwise known as “pills”, which are the main product of big pharma.

Dr. Paul Hermonat and his team continue to revolutionize the industry with an important breakthrough for the Houston Gene Therapeutics. With this development, the company sets its eyes on future gene therapy treatments for major diseases of inflammatory disease, cancer, and aging.

November 2020 Updates from CEO, Dr. Paul Hermonat.